focus -WSS

focus

author：fashion 2025-10-01 01:49:36 - browse：9

Cheryl Meier had watched clinical trial enrollment announcements for years — but always for her sons’ type 1 diabetes, never for herself. Her OB-GYN had put her on Effexor for her depression 20 years ago, and it worked well enough — she could sleep for the first time in her life, and she no longer cried at every little thing. But it never worked for her dark thoughts.

But then she retired, and then she had time, and then she saw an email — “I guess once your name gets on a list, it’s there,” she said — for an experimental depression drug called zuranolone.

Unlike today’s crowded market of SSRIs, prescribed once and taken for months, years, or even indefinitely, zuranolone, developed by Sage Therapeutics, promises something different.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： Medicare has a new plan to address drug shortages

entertainment

WSS

How dance can help nurses traumatized by Covid

Sanofi seeks simpler, safer CRISPR sickle cell cure

Key House panel plots a new health care package

Sanofi seeks simpler, safer CRISPR sickle cell cure

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

STAT Virtual Event: The State of Biosimilars: What to Watch

entertainment

focus

Wikipedia

In Memoriam: Notable people who died in 2023

Group opposing PBM reform sets lobbying record

Tori Bowie and the unacceptable rates of Black maternal death

Key House panel plots a new health care package

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Walensky prepares to leave CDC — and Congress — behind

Does aspartame cause cancer? What new WHO guidance says

Jerome Adams on the need for new antivirals for Covid

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

hotspot

Sanofi seeks simpler, safer CRISPR sickle cell cure

At Orexo, a ‘turning point’ for everything but digital health

Everything to know for the next Powerball drawing as jackpot hits $1 billion

Grail faces three suits alleging harassment, retaliation

Medicare to cover more brain scans for Alzheimer’s patients

Sanofi seeks simpler, safer CRISPR sickle cell cure

focus

entertainment

knowledge

knowledge